COVID-19 Crisis Has Stalled Fight Against HIV/AIDS
Efforts to end the global HIV epidemic have slowed as money and attention go toward fighting COVID-19.
HIV/AIDS
Sleep Quality Tied to Poor PrEP Adherence in Younger Black Sexual Minority Men
Researchers sought to assess sleep quality in relation to PrEP adherence among younger Black sexual minority men.
PrEP Stigma High Among US Male Couples
Male couples underestimate the effectiveness of preexposure prophylaxis (PrEP) for HIV prevention.
Computerized Cognitive Training May Improve HIV-Associated Neurocognitive Disorder
Researchers assessed whether computerized cognitive training programs were associated with improvements in overall cognitive and daily function in patients with HIV infection.
Efficacy of COVID-19 Vaccination Significantly Differs by Immunocompromised Condition
Researchers performed a meta-analysis that assessed seroconversion rates associated with COVID-19 vaccination among patients with immunocompromised conditions.
Cerebrospinal Fluid Diffusion of Bictegravir/Emtricitabine/Tenofovir in HIV-Related Central Nervous System Impairment
Researchers sought to determine the effects and cerebrospinal fluid concentrations of treatment with bictegravir, emtricitabine, and tenofovir in patients with HIV-related central nervous system impairment.
Among Persons With HIV, More Finish Short-Course TB Prophylaxis
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy.
Specific Gene Silencing Induces Apoptosis of HIV-Infected Macrophages
Investigators performed a genome-wide screening study to determine whether silencing specific genes induces apoptosis of HIV-infected macrophages.
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
For men who have sex with men and transgender women, long-acting injectable cabotegravir, is superior to TDF-FTC for preventing HIV infection.
Lenacapavir NDA Submitted for HIV-1 in Heavily Treatment Experienced Patients
Lenacapavir is an investigational, long-acting HIV-1 capsid inhibitor designed to inhibit HIV replication at multiple stages of its lifecycle.
- Loading...
Loading...
Next post in General Neurology
Loading... 
Loading...